Diabetes mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Visited UNISMILE Pharmacy Nasushiobara during the recruitment period (first 2 months) 2. Diagnosed with type 2 diabetes and prescribed antidiabetic medications (injectable or oral) 3. Receiving prescription-based dispensing 4. Provided informed consent after understanding the study purpose.
Exclusion criteria
Exclusion criteria: 1. Evident cognitive impairment hindering study participation. 2. Visual impairment preventing comprehension of educational materials. 3. Expected relocation or hospital transfer preventing continuous pharmacy visits during study period. 4. Ophthalmology visit within 1 year prior to enrollment (verified by My Number Card or self-report) 5. Lack of consent capacity or absence at time of consent. 6. Declined participation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ophthalmology visit rate within 4 months from baseline (comparison between intervention and control groups) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Ophthalmology visit within 2 months from the initial contact (interim evaluation) 2. Association between patient background factors (HbA1c level, age, sex) and ophthalmology visit behavior. 3. Comparison of ophthalmology visit rates by background factors within each group. 4. Difference in the impact of background factors between the two groups (interaction) 5. Exploratory assessment of ophthalmology visit behavior patterns by patient background characteristics. | — |
Countries
Japan
Contacts
UNISMILE Co., Ltd. UNISMILE Pharmacy Nasushiobara